Atlas Trials

Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites

Clinical trial NCT03107091 · COMPLETED

Trial details

NCT number
NCT03107091
Sponsor
BioVie Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
CirrhosisAscites Hepatic
Start date
2017-07-15
Primary completion
2019-04-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.